Skip to main content

Table 1 Clinicopathological characteristics of the diffusely infiltrating astrocytoma patients (n = 150) according to WHO classification

From: Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas

Variable

Grade II

Grade III

Grade IV

Total

Number of cases

25 (16.7%)

6 (4.0%)

119 (79.3%)

150 (100.0%)

Gender

 Male

20 (80.0%)

1 (16.7%)

66 (55.5%)

87 (58.0%)

 Female

5 (20.0%)

5 (83.3%)

53 (44.5%)

63 (42.0%)

Mean age at time of diagnosis (years)

40.6

46.2

58.3

54.8

Mean survival time (months)

36.5

29.5

13.4

18.0

Alive

 Yes

9 (36.0%)

2 (33.3%)

6 (5.0%)

17 (11.3%)

 No

16 (64.0%)

3 (50.0%)

108 (90.8%)

127 (84.7%)

 No information

0 (0.0%)

1 (16.7%)

5 (4.2%)

6 (4.0%)

Cause of death

 Glioma

16 (100.0%)

3 (100.0%)

108 (100.0%)

127 (100.0%)

 Other causes

0 (0.0%)

0 (0.0%)

0 (0.0%)

 

Surgical operation

 No

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

 Resection

21 (84.0%)

6 (100.0%)

114 (95.8%)

141 (94.0%)

 Biopsy

4 (16.0%)

0 (0.0%)

4 (3.4%)

8 (5.3%)

 No information

0 (0.0%)

0 (0.0%)

1 (0.8%)

1 (0.7%)